HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Romero Selected Research

Spontaneous Rupture

10/2000Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes.
10/2000Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection.
6/2000A study of the relationship between placenta growth factor and gestational age, parturition, rupture of membranes, and intrauterine infection.
1/2000Interleukin 16 in pregnancy, parturition, rupture of fetal membranes, and microbial invasion of the amniotic cavity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Romero Research Topics

Disease

26Infections
07/2012 - 01/2000
23Inflammation (Inflammations)
01/2020 - 01/2000
19Rupture
07/2011 - 01/2000
17Premature Obstetric Labor (Premature Labor)
03/2015 - 01/2000
11Chorioamnionitis
09/2010 - 03/2000
9Pre-Eclampsia (Preeclampsia)
03/2015 - 06/2000
8Premature Birth (Birth, Premature)
01/2022 - 11/2000
6Proteinuria
10/2010 - 01/2000
5Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
03/2017 - 10/2000
4Fetal Death
01/2021 - 09/2002
4Birth Weight (Birth Weights)
03/2017 - 03/2001
4Spontaneous Rupture
10/2000 - 01/2000
3Insulin Resistance
01/2018 - 02/2000
3Obesity
01/2018 - 02/2007
3Dyslipidemias (Dyslipidemia)
01/2018 - 11/2005
3Perinatal Death
03/2017 - 05/2000
3Atherosclerosis
10/2010 - 09/2000
3Diabetes Mellitus
09/2007 - 02/2007
3fetal inflammatory response syndrome
11/2006 - 11/2000
3Acute Kidney Injury (Acute Renal Failure)
01/2005 - 01/2001
3Preterm Premature Rupture of the Membranes
11/2001 - 01/2000
2Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 08/2000
2Fever (Fevers)
04/2013 - 01/2005
2Wounds and Injuries (Trauma)
07/2012 - 10/2000
2Secondary Hyperparathyroidism
03/2011 - 10/2010
2Necrosis
10/2010 - 04/2001
2Kidney Diseases (Kidney Disease)
07/2009 - 10/2001
2Weight Loss (Weight Reduction)
02/2007 - 06/2006
2Vasculitis (Vasculitides)
01/2005 - 01/2002
2Hypertension (High Blood Pressure)
01/2005 - 01/2000
2Neonatal Sepsis
08/2003 - 11/2000
2Autoimmune Hepatitis
06/2003 - 12/2002
2Rhabdomyolysis
09/2001 - 09/2000
2Bronchopulmonary Dysplasia
03/2001 - 10/2000
2Injection Site Reaction
05/2000 - 05/2000
1Tuberculosis (Tuberculoses)
10/2020
1Hypoglycemia (Reactive Hypoglycemia)
01/2020
1Sudden Infant Death (SID)
02/2019
1Fibrosis (Cirrhosis)
01/2018
1Disease Progression
01/2018
1Non-alcoholic Fatty Liver Disease
01/2018

Drug/Important Bio-Agent (IBA)

13Interleukin-6 (Interleukin 6)IBA
07/2009 - 03/2000
8CreatinineIBA
07/2009 - 08/2000
7CytokinesIBA
02/2011 - 01/2000
7C-Reactive ProteinIBA
10/2010 - 08/2003
6ProgesteroneFDA LinkGeneric
01/2022 - 12/2006
6Anti-Bacterial Agents (Antibiotics)IBA
07/2012 - 11/2001
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2010 - 11/2000
4Proteins (Proteins, Gene)FDA Link
02/2011 - 10/2000
4Biomarkers (Surrogate Marker)IBA
02/2011 - 08/2001
4Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA
10/2010 - 02/2007
4Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
11/2001 - 07/2000
3InterleukinsIBA
01/2020 - 03/2000
3LipidsIBA
01/2018 - 11/2005
3Peptides (Polypeptides)IBA
03/2015 - 07/2009
3SteroidsIBA
04/2013 - 03/2001
3Biological ProductsIBA
02/2011 - 11/2000
3Pharmaceutical PreparationsIBA
07/2009 - 09/2000
3Atorvastatin (Lipitor)FDA Link
07/2009 - 11/2005
3AdiponectinIBA
11/2008 - 06/2006
3Matrix Metalloproteinases (MMPs)IBA
10/2002 - 10/2000
3EnzymesIBA
06/2002 - 10/2000
2Local Anti-Infective Agents (Antiseptics)IBA
07/2012 - 01/2007
2HepcidinsIBA
07/2011 - 07/2009
2Interleukin-8 (Interleukin 8)IBA
10/2010 - 03/2000
2Interleukin-2 Receptors (IL 2 Receptor)IBA
07/2009 - 09/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2009 - 09/2007
2Calcineurin InhibitorsIBA
09/2007 - 09/2007
2Messenger RNA (mRNA)IBA
03/2007 - 12/2006
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2005 - 01/2001
2ThrombinFDA Link
06/2002 - 06/2002
2N 30IBA
06/2002 - 11/2000
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2001 - 11/2001
2Surface-Active Agents (Surfactants)IBA
03/2001 - 10/2000
2CollagenIBA
10/2000 - 07/2000
2atosibanIBA
05/2000 - 05/2000
2Oxytocin Receptors (Oxytocin Receptor)IBA
05/2000 - 05/2000
1antineoplaston A10 (A 10)IBA
01/2021
1Rifampin (Rifampicin)FDA LinkGeneric
10/2020
1InflammasomesIBA
01/2020
1AlarminsIBA
01/2020
1SiliconIBA
02/2019
1CarbonIBA
02/2019
1purified rayonIBA
02/2019
1SolutionsIBA
02/2019
1NitrogenIBA
02/2019
1Plasminogen Activator Inhibitor 1IBA
01/2018
1Plasminogen Activators (Plasminogen Activator)IBA
01/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2015
1Epidermal Growth Factor (EGF)IBA
03/2015
1ErbB Receptors (EGF Receptor)IBA
03/2015

Therapy/Procedure

7Kidney Transplantation
07/2011 - 01/2000
7Therapeutics
01/2011 - 05/2000
5Transplantation
07/2011 - 08/2003
5Liver Transplantation
06/2003 - 10/2001
3Artificial Respiration (Mechanical Ventilation)
01/2020 - 07/2012
3Length of Stay
04/2013 - 06/2003
2Injections
05/2009 - 01/2003
2Bariatric Surgery
04/2008 - 06/2006
2Tocolysis
05/2000 - 05/2000